Sign in

CIK 0001781174

  • Emerging growth company

Acrivon Therapeutics, Inc.

Sign in to watch
Ticker
ACRV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
825125532
Phone
+1 617-207-8979
Business address
480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$37,028
in 8 filings

Net −$37,028. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-17 BAUM CHARLES M Director Grant or award · Stock Option (Right to Buy) +20,275 20,275
2026-05-18 BAUM CHARLES M Director Grant or award +9,366 9,366
2025-06-13 BAUM CHARLES M Director Grant or award · Stock Option (Right to Buy) +20,275 20,275
2024-06-20 BAUM CHARLES M Director Grant or award · Stock Option (Right to Buy) +20,275 20,275
2023-06-22 BAUM CHARLES M Director Grant or award · Stock Option (Right to Buy) +32,500 32,500

Page 1 of 1 · 5 trades